Although differences in levels of PSG7, PSG9 and PSG1 proteins (all encoded by polymorphic pseudogenes) have been proposed as biomarkers for preeclampsia (Kandel et al. 2022; Toprak et al. 2023), no information regarding the individual genetic variability of these genes was provided in these studies. This evidence concerns the gene PSG1 and preeclampsia.